A Multicenter Study to Monitor for the Potential Development of Renal Tumors in Subjects With Transfusional Iron Overload Who Were Previously Exposed to Deferitazole
Latest Information Update: 19 Aug 2021
At a glance
- Drugs Deferitazole (Primary)
- Indications Iron overload
- Focus Therapeutic Use
- Sponsors Shire
- 19 Aug 2021 New trial record